We are pleased to announce that DuoGenic StemCells Co. has made an agreement with Amerigo Scientific, Inc., effective from 1, December 2024. Amerigo Scientific is appointed […]
We are pleased to announce that DuoGenic StemCells Co. has made an agreement with Symphony Biomedicine Co. Ltd., effective from 01, November 2024. Symphony Biomedicine is […]
A new way to treat joint diseases could follow from the first demonstration of using immune cells to produce collagen. In a promising development for treating […]